DAFNA Capital Management’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

DAFNA Capital Management’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-12,528	Closed	-$328K	–	81
2017 Q1	$328K	Hold	12,528	–	–	0.28%	61
2016 Q4	$222K	Hold	12,528	–	–	0.2%	60
2016 Q3	$296K	Buy	+12,528	New	+$303K	0.21%	62
2016 Q2	–	Sell	-30,000	Closed	-$1.32M	–	104
2016 Q1	$1.32M	Hold	30,000	–	–	1.14%	28
2015 Q4	$1.64M	Hold	30,000	–	–	1.46%	21
2015 Q3	$1.26M	Hold	30,000	–	–	1.25%	26
2015 Q2	$1.56M	Buy	+30,000	New	+$1.61M	1.32%	27

Other funds holding CYAD

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

DAFNA Capital Management's CYAD Position: Q2 2017 in Review

DAFNA Capital Management sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q2 2017, closing a stake of 12,528 shares — an estimated $328K sold.

DAFNA Capital Management first reported a position in CYAD in Q2 2015 and held it in 7 quarters. The position peaked at $1.64M in Q4 2015. 4 funds tracked by Wall St. Rank hold CYAD as of Q2 2017.

DAFNA Capital Management reported no remaining Celyad Oncology SA American Depositary Shares position as of Q2 2017 after selling out during the quarter.
DAFNA Capital Management sold 12,528 Celyad Oncology SA American Depositary Shares shares in Q2 2017, an estimated $328K.
DAFNA Capital Management first reported a position in Celyad Oncology SA American Depositary Shares in Q2 2015 and held it in 7 quarters.
DAFNA Capital Management's Celyad Oncology SA American Depositary Shares position peaked at $1.64M in Q4 2015.
4 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q2 2017.

Based on DAFNA Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.